The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s molecular cytogenetics market report forecasts the molecular cytogenetics market size to grow to $3.85 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Molecular Cytogenetics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

Molecular Cytogenetics Market Size Forecast
The global molecular cytogenetics market is expected to grow from $2.39 billion in 2022 to $2.65 billion in 2023 at a compound annual growth rate (CAGR) of 10.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global molecular cytogenetics market size is expected to reach $3.85 billion in 2027 at a CAGR of 9.8%.

North America held the largest molecular cytogenetics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Molecular Cytogenetics Market Driver ­– Increase In The Incidence Of Genetic Disorders And Cancer
According to the American Cancer Society, a non-profit organisation located in the United States, the global burden of cancer is anticipated to reach 27.5 million new cases and 16.3 million deaths by 2040. Furthermore, in 2022, there will be 1,918,030 new cancer cases and 609,360 cancer fatalities in the United States, with lung cancer accounting for around 350 deaths every day. As a result, the rising prevalence of genetic disorders and cancer is propelling the molecular cytogenetics market forward.

Request for A Sample Of The Global Molecular Cytogenetics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10096&type=smp

Key Molecular Cytogenetics Market Trend – Product Innovations
Major players in the molecular cytogenetics market are implementing new technologies to increase their market position. For example, Agilent Technologies Inc, a US-based firm that supplies laboratory instruments, software, services, and consumables, announced three new microarrays in March 2020 to meet the demands of cytogenetic laboratories for both prenatal and postnatal research. The Agilent GenetiSure Cyto microarrays offer therapeutically relevant content from the databases that has been updated. It would detect copy number variations and copy-neutral loss of heterozygozity in constitutional DNA samples, which have been linked to developmental delay, neuropsychiatric disorders, intellectual incapacity, and congenital malformations.

Molecular Cytogenetics Market Segment
1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users

Molecular Cytogenetics Market Major Players and Strategies
Major players in the molecular cytogenetics market are Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, and Cytognomix Inc.

Calibre Scientific, a US-based supplier of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities, purchased AmpliTech in January 2022 for an unknown sum. Calibre Scientific will add another significant brand to its European distribution segment with this acquisition. AmpliTech is a molecular pathology, cytogenetics, and molecular genetics (prenatal, postnatal, and cancer) company established in France.

The Molecular Cytogenetics Global Market Report 2023 covers regional data on molecular cytogenetics market size, molecular cytogenetics market trends and drivers, opportunities, strategies, and molecular cytogenetics market competitor analysis. The countries covered in the molecular cytogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Molecular cytogenetics is a group of procedures that work with the entire genome or with specific DNA sequences. It encompasses chromosomal and nucleus structural and functional organisation, genome variation, expression, evolution, chromosome abnormalities, and genomic variations in the context of medical genetics and tumour genetics.

 View More Reports Related To The Molecular Cytogenetics Market –
Molecular Diagnostics Devices And Equipment Global Market Report 2023
Molecular Biology Enzymes And Kits And Reagents Global Market Report 2023
Marketing Automation Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: